Panel discussion will share insights on verification modernization, data transformation, and community engagement strategies at the 2026 State Healthcare IT…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…